CCT369260

DESCRIPTION

CCT369260 (compound 1), an orally active inhibitor targeting B-cell lymphoma 6 (BCL6), demonstrates anti-tumor efficacy with an IC50 value of 520 nM [1].

DETAILS

Cas: 2647503-57-7
Purity: 98%
Smiles: C(CC(C)(C)O)N1C=2C(N(C)C1=O)=CC=C(NC3=NC(=NC=C3Cl)N4C[C@@H](C)C(F)(F)[C@@H](C)C4)C2
Category: Compound
Molecular Weight: 508.99
Molecular Formula: C24H31ClF2N6O2

Lead Time: 4 - 5 weeks